Goldman Sachs’s Zevra Therapeutics ZVRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.3M Buy
374,792
+179,979
+92% +$1.59M ﹤0.01% 3106
2025
Q1
$1.46M Sell
194,813
-55,122
-22% -$413K ﹤0.01% 3565
2024
Q4
$2.08M Buy
249,935
+124,100
+99% +$1.03M ﹤0.01% 3448
2024
Q3
$873K Buy
125,835
+91,355
+265% +$634K ﹤0.01% 3832
2024
Q2
$169K Buy
34,480
+14,455
+72% +$70.8K ﹤0.01% 4406
2024
Q1
$116K Sell
20,025
-15,678
-44% -$90.9K ﹤0.01% 4435
2023
Q4
$234K Buy
35,703
+5,337
+18% +$35K ﹤0.01% 4274
2023
Q3
$146K Sell
30,366
-6,257
-17% -$30.2K ﹤0.01% 4321
2023
Q2
$187K Buy
36,623
+3,792
+12% +$19.3K ﹤0.01% 4416
2023
Q1
$181K Buy
32,831
+9,507
+41% +$52.3K ﹤0.01% 4551
2022
Q4
$107K Sell
23,324
-3,089
-12% -$14.2K ﹤0.01% 4662
2022
Q3
$165K Sell
26,413
-50,727
-66% -$317K ﹤0.01% 4780
2022
Q2
$344K Sell
77,140
-75,018
-49% -$335K ﹤0.01% 4613
2022
Q1
$766K Sell
152,158
-38,632
-20% -$194K ﹤0.01% 4306
2021
Q4
$1.66M Buy
190,790
+22,101
+13% +$193K ﹤0.01% 3631
2021
Q3
$1.57M Buy
+168,689
New +$1.57M ﹤0.01% 3659
2021
Q2
Sell
-33,907
Closed -$312K 5576
2021
Q1
$312K Buy
+33,907
New +$312K ﹤0.01% 4618
2020
Q2
Sell
-2,410
Closed -$9K 4577
2020
Q1
$9K Buy
2,410
+3
+0.1% +$11 ﹤0.01% 4392
2019
Q4
$15K Sell
2,407
-100
-4% -$623 ﹤0.01% 4259
2019
Q3
$28K Buy
+2,507
New +$28K ﹤0.01% 4171
2018
Q3
Sell
-1,414
Closed -$147K 4258
2018
Q2
$147K Buy
+1,414
New +$147K ﹤0.01% 3948
2017
Q3
Sell
-1,111
Closed -$71K 4428
2017
Q2
$71K Sell
1,111
-123
-10% -$7.86K ﹤0.01% 4205
2017
Q1
$97K Sell
1,234
-59
-5% -$4.64K ﹤0.01% 4121
2016
Q4
$61K Buy
1,293
+70
+6% +$3.3K ﹤0.01% 4206
2016
Q3
$88K Buy
1,223
+240
+24% +$17.3K ﹤0.01% 4215
2016
Q2
$63K Sell
983
-4,377
-82% -$281K ﹤0.01% 4229
2016
Q1
$1.24M Buy
5,360
+1,453
+37% +$337K ﹤0.01% 2766
2015
Q4
$1.24M Buy
+3,907
New +$1.24M ﹤0.01% 2787